Between 1970 and 1995, the incidence of new NHL cases increased. Between 2007 and 2016, new cases declined by approximately 0.9% per year, and mortality from NHL decreased by 2.2% per year. 3 ...

Only 23.9% of the patients were assigned the correct Emergency Severity Index, and 21.5% received timely analgesia. Adherence to existing emergency department (ED) guidelines on the time to first ...

Given the multiple genetic mutations typically present in SM-AHN, optimal approaches for SM-AHN remain elusive. A new review article has been published by Dr. Deepti H. Radia, a British clinician who ...

Detecting synchronous or discordant lymphomas that arise in different anatomical areas is only possible by collecting samples from several sites. A 60-year-old female patient presented with a rare ...

The potential of axonal damage as a biomarker of disease severity and predictor of further outcomes is highlighted by its effect on functional disability, even in early disease stages. Patients who ...

Arrowhead Pharmaceuticals announced the first patient treated in Takeda’s phase 3 REDWOOD trial of fazirsiran (TAK-999/ARO-AAT) for patients with alpha-1 antitrypsin deficiency (AATD)-associated liver ...

A patient presented with task-related isolated transient weakness in her right hand, which started 15 years before and lasted for 9 years without worsening or improvement. Distal myasthenia gravis (MG ...

Delaying chemotherapy in favor of corticosteroids alone may make treatment less effective and speed up the patient’s decline. A case of acute lymphoblastic leukemia (ALL) complicated by bullous ...

For the last 3 years, the PBC Foundation, based in Edinburgh, Scotland, has conducted an annual summit that addresses the challenges and potential remedies for those living with primary biliary ...

The vast majority (88%) of intrahepatic cholangiocarcinoma in the Western cohort was small duct type, unlike in East Asian cohorts. Just over half of intrahepatic cholangiocarcinoma (iCCA) specimens ...

An evaluation of systemic adverse events that occurred during the course of venom immunotherapy revealed a clear difference between honeybee and wasp venom immunotherapy. A strong association has been ...

The panel identified short-term treatment goals, including pustule clearance within 7 days and a reduction of at least 4 points in skin itching and pain. A global Delphi panel of physicians and ...